The Hematology Journal · 2004 · 110 citations · 33 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesAcquired ResistanceChemotherapy ResistanceOncogene MutationsOncogenic Signaling PathwaysReceptor Tyrosine Kinase OncogenesTherapeutic ResistanceBcr-abl InhibitorsBcr-abl1 Fusion GeneKinase Domain MutationsKinase Inhibitor ResistanceKinase Mutation-mediated ResistanceOncogenic Receptor Tyrosine Kinase MutationsResistance To Tyrosine Kinase InhibitorsSecondary Resistance To Imatinib
33
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Thomas H. Schindler, William G. Bornmann, Patricia Pellicena et al. · Science · 2000 · 1.8K citations
The molecular biology of chronic myeloid leukemia
Michael W. Deininger, John M. Goldman, Junia V. Melo · Blood · 2000 · 1.6K citations